DrugAug 9, 2023
The Ritedose Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per recall — FDA D-0946-2023
CGMP deviation: product released prior to supplier approval.
Class IIFDA: CompletedThe Ritedose Corporation
Recall history in this database
Classification mix: Class III: 1, Class II: 1.
DrugApr 13, 2022
The Ritedose 23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled recall — FDA D-0745-2022
Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30…
Class IIIFDA: TerminatedThe Ritedose Corporation
Understanding this recall history
This page summarizes recall records in which the official source identifies The Ritedose Corporation as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.